Auranofin is a medicine used to treat a type of arthritis called rheumatoid arthritis. It's taken by mouth. Doctors don't know exactly how it works, but they think it helps the body's immune system and changes how cells break down things inside them. It's generally considered safer than some other arthritis drugs, though it can still cause side effects.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Auranofin, sold as Ridaura and as a generic, is a prescription capsule that contains gold. It is approved for adults with active rheumatoid arthritis, an autoimmune disease in which the immune system inflames the lining of the joints, causing pain, swelling and stiffness that can damage the joints over time. It is meant for people whose arthritis stays active despite full doses of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen, or who cannot tolerate them. Auranofin belongs to an older group of treatments called gold therapy, and it is the only form taken by mouth; the others are injections. It is a disease-modifying antirheumatic drug (DMARD), meaning it aims to calm the underlying disease rather than only ease pain. Its benefit is real but modest, smaller than that of methotrexate, which is usually the first DMARD rheumatologists choose. For that reason auranofin is now used far less often, mainly when other options have not worked or are not suitable. It is not approved for children.
No one knows exactly how auranofin works. It appears to dampen the overactive immune activity that drives joint inflammation in rheumatoid arthritis, which shows up as fewer tender joints, less pain and lower blood markers of inflammation. The gold in auranofin builds up in the body slowly. Blood gold levels take about three months to level off, and the body clears gold slowly too, which helps explain why benefits arrive late and why side effects can appear months into treatment. Auranofin does not repair cartilage or bone that the disease has already damaged; its greatest value is in active inflammation, especially early in the disease.
Auranofin comes as a 3 mg capsule. The usual adult dose is 6 mg a day, taken either as 3 mg twice a day or 6 mg once a day. Starting higher is not recommended because it makes diarrhea more likely. If the response is not good enough after six months, the prescriber may raise the dose to 9 mg a day (3 mg three times a day). If there is still not enough improvement after three months at that dose, auranofin is normally stopped and another treatment considered. Doses above 9 mg a day have not been studied, and higher blood gold levels have not been shown to work better. It is usually taken alongside an NSAID and non-drug measures such as exercise and joint protection.
Loose stools or diarrhea are the most common side effect, affecting about half of people. They are usually manageable by lowering the dose, and only a small share of people need to stop for this reason. Abdominal pain, nausea, rash, itching and mouth sores are also common, and some people notice a change in taste, hair thinning or eye irritation. Because auranofin contains gold, it can cause gold toxicity, which carries a boxed warning (the strongest warning the US Food and Drug Administration puts on a label). The concern is damage to the blood-forming cells or the kidneys. Low platelets (the cells that help blood clot) occur in roughly 1 to 3 percent of people, can develop quickly at any point in treatment, and usually reverse once the drug is stopped. Rarely, gold can severely suppress the bone marrow, inflame the bowel or lungs, or affect the liver or nerves. Contact the prescriber promptly, before the next dose, about any new fever, chills or sore throat (possible signs of a falling white cell count), itching or rash, mouth sores or a metallic taste (which can come before mouth sores), unusual bruising, tiny red or purple spots on the skin, bleeding gums, blood in the urine, persistent diarrhea, or blood in the stool or black stools. These can be early signs of a gold reaction, and catching them early is what allows the problem to settle.
Auranofin is not used in people who have previously had a serious reaction to any gold treatment, such as anaphylaxis (a severe allergic reaction), severe skin peeling, scarring of the lungs, serious bowel inflammation or a dangerous drop in blood cells. In people with kidney or liver disease, inflammatory bowel disease, an ongoing skin rash or past bone marrow problems, the prescriber weighs the benefit carefully, because these conditions make gold toxicity both more harmful and harder to spot. It is not known whether auranofin is safe to combine with injectable gold, hydroxychloroquine (Plaquenil, an antimalarial medicine also used to treat arthritis), penicillamine (an older arthritis medicine), high-dose steroids or immune-suppressing drugs such as methotrexate, azathioprine or cyclophosphamide. If you take or are offered any of these, ask the rheumatologist before using it together with auranofin rather than combining them on your own. One case report suggests auranofin may raise blood levels of phenytoin, an anti-seizure medicine. Keep the prescriber and pharmacist informed of every medicine and supplement you take. Auranofin is not recommended during pregnancy, because it caused birth defects in animal studies, and anyone who could become pregnant should discuss this before starting. Breastfeeding is not recommended while taking it, because gold from gold medicines passes into breast milk.
Auranofin works slowly. Improvement in joint pain, swelling and morning stiffness typically begins after three to four months, and some people see no change until about six months. Pain relievers and NSAIDs usually continue in the meantime. Monitoring is a central part of treatment. Before the first prescription, you will have a complete blood count, a platelet count, a urine test and kidney and liver tests. A blood count with platelets and a urine test are then repeated at least every month for as long as you take it, and the prescriber reviews the results before each refill. These tests catch falling blood counts or protein and blood in the urine, often before symptoms appear. Kidney problems caught early usually settle completely once auranofin is stopped, but can become lasting if treatment continues. Side effects are most common in the first six months but can start after many months. If auranofin helps and is tolerated, it can be continued with ongoing monitoring; if it does not help enough, a rheumatologist has several more effective options to consider.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Auranofin, what you've noticed, or ask the community a question.